NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
The NHLBI Emerging Investigator Award (EIA) provides up to seven years of long-term, primary funding for eligible investigators to run an NHLBI-scoped research program in heart, lung, blood, and sleep research. It is designed to boost scientific productivity and innovation by giving experienced investigators greater flexibility to pursue higher-risk, longer-term directions. The award supports …
Source
Award
Dates
Eligibility
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
National Institutes of Health
-
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
National Institutes of Health
-
DoW Bone Marrow Failure, Idea Development Award
Defense Health Agency Contracting Activity - DHACA
-
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
National Institutes of Health
-
NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers